Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:56PM EDT. Market open.
| Previous Close | 900.16 |
| Open | 905.66 |
| Bid | 907.36 x 100 |
| Ask | 909.05 x 100 |
| Day's Range | 903.83 - 912.74 |
| 52 Week Range | 684.81 - 998.33 |
| Volume | |
| Avg. Volume | 465,714 |
| Market Cap | 99.699B |
| Beta (5Y Monthly) | 0.14 |
| PE Ratio (TTM) | 26.14 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
Agenus (AGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
- Simply Wall St.
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
Over the past year, many Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) insiders sold a significant stake in the...
- Zacks
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
© 2024 Yahoo. All rights reserved.